Cargando…

Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data

PURPOSE: To describe a methodology, based on cluster analysis, to partition multi-parametric functional imaging data into groups (or clusters) of similar functional characteristics, with the aim of characterizing functional heterogeneity within head and neck tumour volumes. To evaluate the performan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borri, Marco, Schmidt, Maria A., Powell, Ceri, Koh, Dow-Mu, Riddell, Angela M., Partridge, Mike, Bhide, Shreerang A., Nutting, Christopher M., Harrington, Kevin J., Newbold, Katie L., Leach, Martin O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580650/ https://www.ncbi.nlm.nih.gov/pubmed/26398888 http://dx.doi.org/10.1371/journal.pone.0138545

Ejemplares similares

Practice patterns for the radical treatment of nasopharyngeal cancer by head and neck oncologists in the United Kingdom
por: Petkar, Imran, et al.
Publicado: (2018)

Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck
por: Welsh, Liam, et al.
Publicado: (2017)

Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer
por: Wong, Kee H., et al.
Publicado: (2017)

MRI-based Assessment of 3D Intrafractional Motion of Head and Neck Cancer for Radiation Therapy
por: Gurney-Champion, Oliver J., et al.
Publicado: (2018)

Repeatability and sensitivity of [Formula: see text] measurements in patients with head and neck squamous cell carcinoma at 3T
por: Panek, Rafal, et al.
Publicado: (2016)

Brain-Sparing Methods for IMRT of Head and Neck Cancer
por: Dunlop, Alex, et al.
Publicado: (2015)

Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study
por: Welsh, Liam, et al.
Publicado: (2015)

The impact of restricted length of treatment field and anthropometric factors on selection of head and neck cancer patients for treatment on the MR-Linac
por: Ng-Cheng-Hin, Brian, et al.
Publicado: (2020)

Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma
por: Lee, Jen Y, et al.
Publicado: (2017)

PET/CT in Radiotherapy Planning for Head and Neck Cancer
por: Newbold, Katie, et al.
Publicado: (2012)

Online adaptive radiotherapy for head and neck cancers on the MR linear Accelerator: Introducing a novel modified Adapt-to-Shape approach
por: Gupta, Amit, et al.
Publicado: (2021)

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer
por: Bhide, S A, et al.
Publicado: (2008)

On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy
por: Nenclares, Pablo, et al.
Publicado: (2021)

Early-Stage Glottic Squamous Cell Carcinoma in the Era of Image-Guided Radiotherapy
por: Gupta, Amit, et al.
Publicado: (2021)

Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy
por: Dean, Jamie, et al.
Publicado: (2017)

HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation
por: McLaughlin, Martin, et al.
Publicado: (2017)

Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy
por: Dean, Jamie A., et al.
Publicado: (2016)

Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma
por: Bhide, S A, et al.
Publicado: (2016)

Comparison of CT number calibration techniques for CBCT-based dose calculation
por: Dunlop, Alex, et al.
Publicado: (2015)

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
por: Nutting, Christopher M, et al.
Publicado: (2011)

DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer
por: Petkar, Imran, et al.
Publicado: (2016)

Supervised Machine-Learning Enables Segmentation and Evaluation of Heterogeneous Post-treatment Changes in Multi-Parametric MRI of Soft-Tissue Sarcoma
por: Blackledge, Matthew D., et al.
Publicado: (2019)

Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway
por: Twigger, Katie, et al.
Publicado: (2012)

The HSP90 Inhibitor NVP-AUY922 Radiosensitizes by Abrogation of Homologous Recombination Resulting in Mitotic Entry with Unresolved DNA Damage
por: Zaidi, Shane, et al.
Publicado: (2012)

Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer
por: Harrington, K.J., et al.
Publicado: (2020)

Radiotherapy in head and neck cancer management: United Kingdom National Multidisciplinary Guidelines
por: Nutting, C
Publicado: (2016)

A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes
por: Miah, A B, et al.
Publicado: (2015)

Safety and Treatment Outcomes of Nivolumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Retrospective Multicenter Cohort Study
por: Vasiliadou, Ifigenia, et al.
Publicado: (2021)

Recent advances in radiotherapy
por: Bhide, SA, et al.
Publicado: (2010)

Liver-specific agents for contrast-enhanced MRI: role in oncological imaging
por: Thian, Yee Liang, et al.
Publicado: (2013)

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer
por: Kirby, A M, et al.
Publicado: (2006)

5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers
por: Liu, Siyu, et al.
Publicado: (2020)

Inter-Observer Variation in Delineating the Pharyngeal Constrictor Muscle as Organ at Risk in Radiotherapy for Head and Neck Cancer
por: Petkar, Imran, et al.
Publicado: (2021)

Magnetic Resonance Imaging–Based Assessment of Breast Cancer–Related Lymphoedema Tissue Composition
por: Borri, Marco, et al.
Publicado: (2017)

Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000
por: Ness, Andrew Robert, et al.
Publicado: (2014)

Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy
por: Miah, A.B., et al.
Publicado: (2016)

Intra-tumor heterogeneity in head and neck cancer and its clinical implications
por: Mroz, Edmund A., et al.
Publicado: (2016)

Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma
por: Mou, Tingchen, et al.
Publicado: (2023)

Quality assurance of dysphagia-optimised intensity modulated radiotherapy treatment planning for head and neck cancer
por: Tyler, Justine, et al.
Publicado: (2021)

Triaging algorithm for head & neck oncology follow-up patients in COVID-19 climate
por: Singh, Mark, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hnu6s0mdr8p02eq1iepgd1po9i